Post-Doctoral Fellow: Nanomedicine and Enzyme Kinetics
University of Basel
Basel, Switzerland
vor 1 Tg.
source : Academic Media Group International AB

The Department of Pharmaceutical Sciences of the University of Basel is an Academic Drug Discovery & Development Center, which comprehensively covers academic drug research throughout pre-clinical and clinical research phases.

The Nanopharmaceutical and Regulatory Science Group (NRSG) within the Department is searching for a PhD-level scientist with training in enzyme kinetics and nanomedicine formulation.

Nanomedicine-based formulations have been used to deliver a wide variety of active pharmaceutical ingredients over the past several decades.

These 'nanoformulations' can favorably alter a small molecule's pharmacokinetic profile and decrease adverse side effects.

Within the NRSG we study peptides and peptidomimetics that influence the activity of various enzymes. This postdoctoral position will investigate the kinetics of these interactions, then encapsulate these molecules into lipid-based nanomedicines.

The candidate will be a scientist with a PhD in a related field (such as chemistry, pharmacy, biology, or medicine), and relevant training / experience with enzyme kinetics and synthesis of lipid-based nanomedicines.

This postdoc will actively collaborate with colleagues in academia and the pharmaceutical industry. Fluency in English is required.

The candidate will join a newly established research group that generates and characterises novel formulations for a variety of clinical indications.

The NRSG emphasizes translational and regulatory sciences, ensuring that resulting drug products can quickly be brought into clinical trials.

The initial contract will be for two years with the possibility of extension.

Melde diesen Job

Thank you for reporting this job!

Your feedback will help us improve the quality of our services.

Klicke auf "Weiter", um unseren Datenschutz-und Nutzungsbestimmungen zuzustimmen . Du kriegst außerdem die besten Jobs als E-Mail-Alert. Los geht's!